December 17, 2024 00:41 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
GRAP 4 restrictions reimposed in Delhi as air quality dips to 'severe' category | 39 ministers included in Devendra Fadnavis-led Maharashtra cabinet | People who raise questions on EVMs should show how they can be hacked: TMC trashes Congress claims | Bangladesh likely to hold national polls in late 2025 or early 2026, says Yunus in Victory Day speech | Constitution stood test of time: Nirmala Sitharaman in Rajya Sabha | PM Museum requests Rahul Gandhi to return Pandit Nehru's historical letters | Indian tabla maestro Zakir Hussain dies at 73 in San Francisco, confirms family | Kolkata woman strangled, beheaded and chopped into pieces for refusing brother-in-law's advances | Arvind Kejriwal, CM Atishi to contest Delhi polls from current constituencies | Atul Subhash suicide case: Wife Nikita, her mother and brother arrested
Cipla promoters sell 2.53% stake in company for Rs 2,637 cr

Cipla promoters sell 2.53% stake in company for Rs 2,637 cr

May 15, 2024, at 10:18 pm

Mumbai: The promoters of Cipla have sold a 2.53% stake in the company for 'creating liquidity' for specific needs including 'philanthropy', the Mumbai headquartered pharma major said on Wednesday.

Cipla Q4FY24: Net profit grows 79% YoY to Rs 939 cr

Cipla Q4FY24: Net profit grows 79% YoY to Rs 939 cr

May 10, 2024, at 10:21 pm

Mumbai: Pharma giant Cipla’s consolidated net profit grew 79% rising to Rs 939.04 crore in Q4 FY24 over Q4 FY23.

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Mar 27, 2024, at 06:16 am

Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.

Cipla's portable, wireless spirometer to ease diagnosis of COPD, asthma

Cipla's portable, wireless spirometer to ease diagnosis of COPD, asthma

Nov 17, 2021, at 02:37 pm

Mumbai/IBNS: Indian multinational pharma giant Cipla Limited  (BSE:  500087;  NSE:  CIPLA  EQ)  Wednesday announced  the launch  of  Spirofy, India's first pneumotach based portable, wireless spirometer, on World COPD Day, the company said in a BSE filing.

Cinacalcet tablets case: Cipla, Amgen settle legal dispute

Cinacalcet tablets case: Cipla, Amgen settle legal dispute

Jul 20, 2020, at 10:45 pm

Mumbai/UNI: Pharma major, Cipla on Monday said company has settled a a legal dispute with Amgen in the United States involving generic cinacalcet hydrochloride tablets , used in treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease.